Overview

Zynrelef Versus Adductor Canal Block

Status:
NOT_YET_RECRUITING

Trial end date:
2028-01-01

Target enrollment:

Participant gender:

Summary

To compare postoperative MME consumption 72 hours after TKA in patients receiving intraoperative periarticular HTX-011 (Zynrelef) instillation versus adductor canal block.

Phase:

PHASE4

Details

Lead Sponsor:

University of Miami

Treatments:

bupivacaine-meloxicam drug combination
Ropivacaine